Whan In Pharm Co.,Ltd. (KRX:016580)
10,630
+80 (0.76%)
Apr 24, 2026, 3:30 PM KST
Whan In Pharm Revenue
In the year 2025, Whan In Pharm had annual revenue of 255.21B KRW, down -1.69%. Whan In Pharm had revenue of 65.14B in the quarter ending December 31, 2025, a decrease of -1.67%.
Revenue
255.21B
Revenue Growth
-1.69%
P/S Ratio
0.77
Revenue / Employee
424.65M
Employees
601
Market Cap
196.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 255.21B | -4.38B | -1.69% |
| Dec 31, 2024 | 259.60B | 29.20B | 12.68% |
| Dec 31, 2023 | 230.39B | 31.46B | 15.81% |
| Dec 31, 2022 | 198.93B | 21.16B | 11.90% |
| Dec 31, 2021 | 177.78B | 6.07B | 3.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Suheung | 722.31B |
| Daewon Pharmaceutical | 605.43B |
| Jeil Pharmaceutical Co.,Ltd | 567.24B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| JW Lifescience | 257.83B |
| Samil Pharmaceutical Co.,Ltd | 210.25B |
| REYON Pharmaceutical | 145.93B |
| Hana Pharm | 139.33B |